Transcat (NASDAQ:TRNS) Price Target Increased to $103.00 by Analysts at Craig Hallum

Transcat (NASDAQ:TRNS – Get Rating) had its target price lifted by Craig Hallum from $92.00 to $103.00 in a report released on Wednesday morning, The Fly reports.

Several other brokerages have also issued reports on TRNS. Roth Capital lifted their price target on Transcat from $80.00 to $94.00 and gave the company a buy rating in a report on Thursday, February 2nd. Northland Securities lifted their price target on Transcat from $100.00 to $110.00 in a report on Wednesday. HC Wainwright lifted their price target on Transcat from $96.00 to $102.00 in a report on Wednesday. Finally, StockNews.com started coverage on Transcat in a report on Thursday, May 18th. They set a hold rating for the company. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Transcat has a consensus rating of Moderate Buy and an average target price of $102.25.

Transcat Stock Down 1.9 %

Shares of Transcat stock opened at $89.67 on Wednesday. The firm has a market cap of $685.08 million, a price-to-earnings ratio of 64.05 and a beta of 0.76. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.42 and a quick ratio of 1.75. Transcat has a 52-week low of $50.32 and a 52-week high of $94.10. The stock has a 50-day simple moving average of $83.92 and a 200-day simple moving average of $81.90.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Neuberger Berman Group LLC raised its stake in shares of Transcat by 0.4% in the 4th quarter. Neuberger Berman Group LLC now owns 842,398 shares of the scientific and technical instruments company’s stock valued at $59,701,000 after acquiring an additional 3,506 shares in the last quarter. Conestoga Capital Advisors LLC increased its position in Transcat by 0.6% in the 1st quarter. Conestoga Capital Advisors LLC now owns 731,044 shares of the scientific and technical instruments company’s stock worth $65,348,000 after buying an additional 4,217 shares during the period. Fred Alger Management LLC increased its position in Transcat by 6.1% in the 1st quarter. Fred Alger Management LLC now owns 727,225 shares of the scientific and technical instruments company’s stock worth $65,007,000 after buying an additional 41,563 shares during the period. Broadcrest Asset Management LLC increased its position in Transcat by 8.9% in the 4th quarter. Broadcrest Asset Management LLC now owns 490,000 shares of the scientific and technical instruments company’s stock worth $34,726,000 after buying an additional 40,000 shares during the period. Finally, BlackRock Inc. increased its position in Transcat by 0.5% in the 1st quarter. BlackRock Inc. now owns 457,722 shares of the scientific and technical instruments company’s stock worth $40,916,000 after buying an additional 2,270 shares during the period. 83.24% of the stock is owned by institutional investors.

About Transcat

(Get Rating)

Transcat, Inc engages in provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade test, measurement, and control instrumentation.